Ashley Brant
Ashley Brant is a seasoned leader in the bioanalytical industry with over 25 years of experience in driving process improvements that enhance productivity and ensure regulatory compliance across both large and small molecule bioanalytical streams. Ashley’s career began after earning her biochemistry degree from Eastern Michigan University, performing EGFR receptor research with Elizabeth Butch. She […]
Antonia Wierzbicki
Antonia Wierzbicki is a Principal Market Development Manager at Waters, supporting the EMEA region. She holds a BSc in Pharmaceutical Science and an MSc in Cancer Pharmacology. Antonia began her career as an analytical chemist, working in drug development across both academic laboratories and contract research organisations. Building on this foundation, she now partners closely […]
Quality control, and reference standards, in the GLP-1 era
The evolution of GLP-1 drugs from successful diabetes treatments to industry-shaping obesity products has brought with it critical quality control and regulatory compliance challenges. This session will discuss how pharma manufacturers can ensure test methods’ analytical accuracy when identifying and controlling impurities, including:
Dan Bach Christensen
Dan Bach Kristensen holds a Ph.D. in biology and B.Sc. degree in chemistry. Dan is specialized in protein chemistry and mass spectrometry, which he initially applied in the field of proteome research in Japan and later in Denmark. For the last 17 years Dan has been working with analytical development in the biopharmaceutical industry, on […]
Next-Gen Biologics Characterisation:
Pushing Boundaries
